• Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of EDIT-301 at the ASH 2023 Annual Meeting and in a Company-sponsored Webinar

    Источник: Nasdaq GlobeNewswire / 02 ноя 2023 09:12:24   America/New_York

    N/A
Опубликовать